• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解在“检测不到即无法传播”时代人类免疫缺陷病毒(HIV)病毒学失败的风险。

Understanding the Risk of Human Immunodeficiency Virus (HIV) Virologic Failure in the Era of Undetectable Equals Untransmittable.

机构信息

New York State Department of Health, Albany, NY, USA.

United States Public Health Service, Washington, USA.

出版信息

AIDS Behav. 2021 Jul;25(7):2259-2265. doi: 10.1007/s10461-020-03154-z. Epub 2021 Jan 13.

DOI:10.1007/s10461-020-03154-z
PMID:33439374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8165059/
Abstract

The "Undetectable = Untransmittable" campaign indicates that persons living with Human Immunodeficiency Virus (HIV) who maintain a suppressed viral load cannot sexually transmit the virus. However, there is little knowledge of the percent of individuals at a population level who sustain viral suppression long term. The aims of this study were to: (1) establish a baseline of persons living with diagnosed HIV who resided in New York and had consecutive suppressed viral load tests; (2) describe the risk of virologic failure among those who were consecutively suppressed; and (3) gain an understanding of the length of time between consecutive viral suppression to virologic failure. A total of 102,339 New Yorkers aged 13-90 years were living with diagnosed HIV at the beginning of 2012; 47.9% were consecutively suppressed (last two HIV viral load test results from 2010-2011 that were < 420 days apart and < 200 copies/mL). Of consecutively suppressed individuals, 54.3% maintained viral suppression for the entire study period and 33.6% experienced virologic failure during the study period. Among persons who experienced virologic failure, 82.6% did so six or more months after being consecutively suppressed. Our findings support the need for ongoing viral load monitoring, adherence support, and ongoing risk reduction messaging to prevent forward HIV transmission.

摘要

“检测不到=不传播”运动表明,病毒载量受到抑制的艾滋病毒感染者不会通过性行为传播病毒。然而,对于在人群水平上有多少个体能够长期维持病毒抑制知之甚少。本研究的目的是:(1)确定居住在纽约且连续两次病毒载量检测受到抑制的艾滋病毒感染者的基线人数;(2)描述那些连续抑制的人发生病毒学失败的风险;(3)了解连续抑制与病毒学失败之间的时间间隔。在 2012 年初,共有 102339 名年龄在 13-90 岁的纽约人被诊断为艾滋病毒感染者;其中 47.9%的人连续受到抑制(最后两次 HIV 病毒载量检测结果来自 2010-2011 年,间隔时间不到 420 天,且病毒载量低于 200 拷贝/mL)。在连续受到抑制的人群中,54.3%的人在整个研究期间维持病毒抑制,33.6%的人在研究期间发生病毒学失败。在发生病毒学失败的人群中,82.6%的人在连续受到抑制后 6 个月或更长时间出现病毒学失败。我们的研究结果支持需要进行持续的病毒载量监测、依从性支持和持续的风险降低信息传递,以防止艾滋病毒的进一步传播。

相似文献

1
Understanding the Risk of Human Immunodeficiency Virus (HIV) Virologic Failure in the Era of Undetectable Equals Untransmittable.了解在“检测不到即无法传播”时代人类免疫缺陷病毒(HIV)病毒学失败的风险。
AIDS Behav. 2021 Jul;25(7):2259-2265. doi: 10.1007/s10461-020-03154-z. Epub 2021 Jan 13.
2
Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.在一组 HIV 阳性患者中,持续低水平病毒血症后的病毒学失败:12 年观察结果。
Clin Infect Dis. 2013 Nov;57(10):1489-96. doi: 10.1093/cid/cit529. Epub 2013 Aug 14.
3
Prevalence and predictive value of intermittent viremia with combination hiv therapy.联合抗逆转录病毒疗法期间间歇性病毒血症的患病率及预测价值
JAMA. 2001 Jul 11;286(2):171-9. doi: 10.1001/jama.286.2.171.
4
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.人类免疫缺陷病毒基因耐药性检测对治疗效果的影响研究。
Verh K Acad Geneeskd Belg. 2001;63(5):447-73.
5
Longitudinal Viral Suppression Among a Cohort of Adolescents and Young Adults with Behaviorally Acquired Human Immunodeficiency Virus.一组通过行为感染人类免疫缺陷病毒的青少年和青年中的病毒长期抑制情况
AIDS Patient Care STDS. 2017 Sep;31(9):377-383. doi: 10.1089/apc.2017.0078.
6
Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.实现世界卫生组织90%的目标:波兰抗逆转录病毒治疗的疗效与患者基线临床特征相关。
J Int AIDS Soc. 2017 Jul 17;20(1):21847. doi: 10.7448/IAS.20.1.21847.
7
Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.含蛋白酶抑制剂的高效抗逆转录病毒疗法的病毒学转归及病毒学失败的预测因素
AIDS Patient Care STDS. 2001 Apr;15(4):193-9. doi: 10.1089/10872910151133729.
8
Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study.极低水平HIV病毒血症患者的特征分析:一项基于社区的研究。
J Int Assoc Provid AIDS Care. 2017 May/Jun;16(3):261-266. doi: 10.1177/2325957416680028. Epub 2016 Nov 30.
9
Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013.2012 - 2013年美国已确诊感染艾滋病毒者的持久病毒抑制和传播风险潜力
Clin Infect Dis. 2016 Oct 1;63(7):976-83. doi: 10.1093/cid/ciw418. Epub 2016 Jun 29.
10
Effectiveness of integrase strand transfer inhibitors among treatment-experienced patients in a clinical setting.在临床环境中,整合酶抑制剂在治疗经验丰富的患者中的疗效。
AIDS. 2019 Jun 1;33(7):1187-1195. doi: 10.1097/QAD.0000000000002194.

引用本文的文献

1
Extending follow-up visits in people with HIV (PWH) receiving bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) therapy: an expert opinion.延长接受比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺(BIC/FTC/TAF)治疗的HIV感染者(PWH)的随访时间:专家意见
Infez Med. 2025 Sep 1;33(3):268-278. doi: 10.53854/liim-3303-3. eCollection 2025.
2
Combination HIV Prevention Strategies in the Lisbon Cohort of Men who Have Sex with Men: A Longitudinal Cluster Analysis of Data from 2014 to 2021.里斯本男男性行为者队列中的艾滋病病毒联合预防策略:对2014年至2021年数据的纵向聚类分析
AIDS Behav. 2025 Apr 17. doi: 10.1007/s10461-025-04693-z.
3
People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapy.在印度,注射毒品者和感染艾滋病毒的男男性行为者在抗逆转录病毒治疗的头12个月里,病毒反弹的可能性较低,且持续病毒血症水平较高。
AIDS Care. 2025 Jul;37(7):1085-1096. doi: 10.1080/09540121.2025.2484635. Epub 2025 Mar 28.
4
Sexual orientation, gender identity and virologic failure among people with HIV: a cohort study in all of US research program.艾滋病毒感染者的性取向、性别认同和病毒学失败:美国所有研究计划中的一项队列研究。
BMC Public Health. 2024 Aug 2;24(1):2091. doi: 10.1186/s12889-024-19559-7.
5
Predictors of Detectable Viremia, Outcomes, and Implications for Management of People Living With HIV Who Are Receiving Antiretroviral Therapy in Southern Nigeria.尼日利亚南部接受抗逆转录病毒治疗的艾滋病毒感染者可检测到病毒血症的预测因素、结局及管理意义
Open Forum Infect Dis. 2023 Nov 9;10(12):ofad562. doi: 10.1093/ofid/ofad562. eCollection 2023 Dec.
6
Effectiveness and safety of community-led assisted partner service among HIV-diagnosed men who have sex with men: a multicentre, randomized controlled trial in China.社区主导的艾滋病病毒确诊男男性行为者同伴辅助服务的有效性和安全性:一项中国的多中心随机对照试验
Lancet Reg Health West Pac. 2023 May 16;36:100772. doi: 10.1016/j.lanwpc.2023.100772. eCollection 2023 Jul.
7
A Preliminary Test of an mHealth Facilitated Health Coaching Intervention to Improve Medication Adherence among Persons Living with HIV.移动医疗辅助健康教练干预改善 HIV 感染者药物依从性的初步试验。
AIDS Behav. 2021 Nov;25(11):3782-3797. doi: 10.1007/s10461-021-03342-5. Epub 2021 Jun 12.

本文引用的文献

1
Factors associated with a strictly undetectable viral load in HIV-1-infected patients.与 HIV-1 感染患者病毒载量持续不可检测相关的因素。
HIV Med. 2012 Oct;13(9):568-73. doi: 10.1111/j.1468-1293.2012.01012.x. Epub 2012 Mar 21.
2
The challenge of patient adherence.患者依从性的挑战。
Ther Clin Risk Manag. 2005 Sep;1(3):189-99.